OpenURL Connection Search

Select item for more details and to access through your institution.

The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis.
Published in:
2013
By:
- Zeze Fu;
- Biyong Deng;
- Yuxin Liao;
- Liancheng Shan;
- Fei Yin;
- Zhuoying Wang;
- Hui Zeng;
- Dongqing Zuo;
- Yingqi Hua;
- Zhengdong Cai;
- Fu, Zeze;
- Deng, Biyong;
- Liao, Yuxin;
- Shan, Liancheng;
- Yin, Fei;
- Wang, Zhuoying;
- Zeng, Hui;
- Zuo, Dongqing;
- Hua, Yingqi;
- Cai, Zhengdong
Publication type:
journal article
Correlation between Patient‐Derived Xenograft Modeling and Prognosis in Osteosarcoma.
Published in:
Orthopaedic Surgery, 2022, v. 14, n. 6, p. 1161, doi. 10.1111/os.13211
By:
- Sun, Mengxiong;
- Wang, Zongyi;
- Sun, Wei;
- Chen, Ming;
- Ma, Xiaojun;
- Shen, Jiakang;
- Fu, Zeze;
- Zuo, Dongqing;
- Wang, Gangyang;
- Wang, Hongsheng;
- Wang, Chongren;
- Yin, Fei;
- Wang, Zhuoying;
- Zhang, Chuanying;
- Hua, Yingqi;
- Cai, Zhengdong
Publication type:
Article
Alternol, a natural compound, exerts an anti-tumour effect on osteosarcoma by modulating of STAT3 and ROS/ MAPK signalling pathways.
Published in:
Journal of Cellular & Molecular Medicine, 2017, v. 21, n. 2, p. 208, doi. 10.1111/jcmm.12957
By:
- Zuo, Dongqing;
- Zhou, Zifei;
- Wang, Hongsheng;
- Zhang, Tao;
- Zang, Jie;
- Yin, Fei;
- Sun, Wei;
- Chen, Jiepeng;
- Duan, Lili;
- Xu, Jing;
- Wang, Zhuoying;
- Wang, Chongren;
- Lin, Binhui;
- Fu, Zeze;
- Liao, Yuxin;
- Li, Suoyuan;
- Sun, Mengxiong;
- Hua, Yingqi;
- Zheng, Longpo;
- Cai, Zhengdong
Publication type:
Article
Shikonin promotes adriamycin-induced apoptosis by upregulating caspase-3 and caspase-8 in osteosarcoma.
Published in:
Molecular Medicine Reports, 2017, v. 16, n. 2, p. 1347, doi. 10.3892/mmr.2017.6729
By:
- QING YANG;
- SUOYUAN LI;
- ZEZE FU;
- BINHUI LIN;
- ZIFEI ZHOU;
- ZHUOYING WANG;
- YINGQI HUA;
- ZHENGDONG CAI
Publication type:
Article
Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcoma.
Published in:
International Journal of Cancer, 2019, v. 145, n. 4, p. 979, doi. 10.1002/ijc.32180
By:
- Wang, Gangyang;
- Sun, Mengxiong;
- Jiang, Yafei;
- Zhang, Tao;
- Sun, Wei;
- Wang, Hongsheng;
- Yin, Fei;
- Wang, Zhuoying;
- Sang, Weilin;
- Xu, Jing;
- Mao, Min;
- Zuo, Dongqing;
- Zhou, Zifei;
- Wang, Chongren;
- Fu, Zeze;
- Wang, Zongyi;
- Duan, Zhenfeng;
- Hua, Yingqi;
- Cai, Zhengdong
Publication type:
Article

Found: 5

The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis.

Correlation between Patient‐Derived Xenograft Modeling and Prognosis in Osteosarcoma.

Alternol, a natural compound, exerts an anti-tumour effect on osteosarcoma by modulating of STAT3 and ROS/ MAPK signalling pathways.

Shikonin promotes adriamycin-induced apoptosis by upregulating caspase-3 and caspase-8 in osteosarcoma.

Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcoma.